Back to Sarasin & Partners LLP Sarasin & Partners LLP

LLYLLY

Showing 9 of 31 quarters

Position history for Sarasin & Partners LLPSarasin & Partners LLP's holdings in Eli Lilly and Company

Yes. Sarasin & Partners holds 103,935 shares of LLY (Eli Lilly), worth $120.3M, as of its Q3 2026 13F filing. It reduced the position by 6,896 shares (-6.2%) from Q2 2026. Sarasin & Partners has held LLY since Q3 2023, across 13 quarterly 13F filings. LLY is 1.3% of Sarasin & Partners' reported 13F portfolio.

Current Value

$120.3M

Current Shares

103,935

Total Value Change

-$92.6M

Total Shares Change

-136,300

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
103,935
-6.2%
$120.3M1.3%$1,157.08
0
2026-Q2
Decreased
110,831
-9.3%
$132.9M1.6%$1,197.71
0
2026-Q1
Decreased
122,180
-7.1%
$112.4M1.4%$916.88
0
2025-Q4
Decreased
131,497
-6.3%
$141.3M1.5%$1,069.51
0
2025-Q3
Decreased
140,355
-41.0%
$102M1.0%$758.22
0
2025-Q2
Increased
237,793
+4.3%
$185.4M1.8%$772.95
50
2025-Q1
Decreased
228,058
-10.7%
$188.4M2.0%$817.26
0
2024-Q4
Increased
255,495
+6.3%
$197.2M2.2%$762.60
56
2024-Q3
Decreased
240,235
-23.6%
$212.8M2.0%$873.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used